Raleigh Malik

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

Juan P. Frías, Enzo Bonora, Luis Nevárez Ruiz et al. · Diabetes Care · 2021 · 190 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of <scp>AWARD</scp> ‐11

Enzo Bonora, Juan P. Frías, Francisco J. Tinahones et al. · Diabetes Obesity and Metabolism · 2021 · 59 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols

Tahira Khan, Mark Stewart, Samuel C. Blackman et al. · Therapeutic Innovation & Regulatory Science · 2018 · 48 citations

Medicine, Oncology, Pediatrics +14

Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis

Fady T. Botros, Hertzel C. Gerstein, Raleigh Malik et al. · Diabetes Care · 2023 · 37 citations

Medicine, Nephrology, Pharmacotherapy +17

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison

Carel W. le Roux, Emily R. Hankosky, Duzhe Wang et al. · Diabetes Obesity and Metabolism · 2023 · 32 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16